The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women

By Scholes D.   LaCroix A.Z.   Ichikawa L.E.   Barlow W.E.   Ott S.M.  

Contraception, Vol. 69, Iss. 2, 2004-02 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

Growth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells

By Boostanfar R.   Amezcua C.A.   Tourgeman D.E.   Roy S.   Felix J.C.   Stanczyk F.Z.  

Fertility and Sterility, Vol. 79, Iss. 1, 2003-01 ,pp. : 223-225

Elsevier

Access to resources Recommend Favorite

Sequential addition of low dose of medrogestone or medroxyprogesterone acetate to transdermal estradiol: a pilot study on their influence on the endometrium

By Pansini F.   Paoli D.D.   Albertazzi P.   Bonaccorsi G.   Campobasso C.   Zanotti L.   Pisati R.   Giulini N.A.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 68, Iss. 1, 1996-09 ,pp. : 137-141

Elsevier

Access to resources Recommend Favorite

Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate therapy regimen

By Rees M. C. P.   Kuhl H.   Engelstein M.   Mattila L.   Mäenpää J.   Mustonen M.  

Climacteric, Vol. 7, Iss. 1, 2004-01 ,pp. : 23-32

Informa Healthcare

Access to resources Recommend Favorite

Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17β-estradiol and intermittent medroxyprogesterone acetate

By Os I.   Os A.   Abdelnoor M.   Larsen A.   Birkeland K.   Westheim A.  

Climacteric, Vol. 6, Iss. 3, 2003-09 ,pp. : 204-210

Informa Healthcare

Access to resources Recommend Favorite